Use of a modified Atkins diet in intractable childhood epilepsy

Epilepsia. 2007 Jan;48(1):182-6. doi: 10.1111/j.1528-1167.2006.00910.x.

Abstract

Purpose: To evaluate the efficacy, safety and tolerability of a modified Atkins diet in intractable childhood epilepsy.

Methods: Fourteen children with epilepsy were treated prospectively with a modified Atkins diet. Outcome measures included seizure frequency, adverse reactions and tolerability to the diet; blood beta-hydroxybutyrate and urine ketones were also measured.

Results: Six months after diet initiation, seven (50%) remained on the diet, five (36%) had >50% seizure reduction, and three (21%) were seizure free. The diet was well tolerated by 12 (86%) patients. Most complications were transient and were successfully managed by careful follow-up and conservative strategies. A consistently strong ketosis (beta-hydroxybutyrate of >3 mmol/L) seemed to be important for maintaining the efficacy of the diet therapy.

Conclusions: The modified Atkins diet was well tolerated and sometimes a modified Atkins diet can be substituted for the conventional ketogenic diet. Serious complications were rare, but long-term complications remain to be determined.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • 3-Hydroxybutyric Acid / blood
  • 3-Hydroxybutyric Acid / metabolism
  • Age Factors
  • Child
  • Cohort Studies
  • Diet, Carbohydrate-Restricted / adverse effects
  • Diet, Carbohydrate-Restricted / methods*
  • Dietary Proteins / administration & dosage
  • Disease-Free Survival
  • Epilepsy / diet therapy*
  • Epilepsy / metabolism
  • Female
  • Follow-Up Studies
  • Humans
  • Ketones / urine
  • Ketosis / metabolism
  • Male
  • Prospective Studies
  • Treatment Outcome

Substances

  • Dietary Proteins
  • Ketones
  • 3-Hydroxybutyric Acid